Astragaloside inhibits IL-1 β-induced inflammatory response in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice.

Conclusion: Astragaloside potentially serve as a promising and effective therapeutic agent for treating OA patients. PMID: 31293216 [PubMed - as supplied by publisher]
Source: Immunopharmacology and Immunotoxicology - Category: Allergy & Immunology Tags: Immunopharmacol Immunotoxicol Source Type: research